|
|
Substance Name: Iodamide Meglumine [USAN]
RN: 18656-21-8
UNII: 6X283535A3
InChIKey: UYIPQECISAQMIU-WZTVWXICSA-N
Classification Codes
- Diagnostic Aid (Radiopaque Medium)
- Drug / Therapeutic Agent
Molecular Formula
- C12-H11-I3-N2-O4.C7-H17-N-O5
Molecular Weight
- 823.1422
* denotes mobile formatted website
Links to Resources
NLM Resources (File Locators)
Other Resources (Internet Locators)
Search for this InChIKey on the Web
Names and Synonyms
Name of Substance
- Iodamide Meglumine [USAN]
- Iodamide N-methyl-D-glucamine salt
- Meglumine iodamide
Synonyms
- alpha,5-Diacetamido-2,4,6-triiodo-m-toluic acid compound with 1-deoxy-1-(methylamino)-D-glucitol (1:1)
- Benzoic acid, 3-(acetylamino)-5-((acetylamino)methyl)-2,4,6-triiodo-, compound with 1-deoxy-1-(methylamino)-D-glucitol (1:1)
- Conraxin H
- EINECS 242-480-6
- Iodamide 300
- Iodamide meglumine
- Iodamide methylglucamine
- Isteropac E.R.
- Jodamid methylglucaminsalz
- Jodamid methylglucaminsalz [German]
- Meglumine iodamide
- Meglumine iodamide injection
- Meglumine Sodium Iodamide Injection [JAN]
- Opacist E.R.
- Renovue
- Renovue-65
- Renovue-DIP
- UNII-6X283535A3
Systematic Names
- 1-Deoxy-1-(methylamino)-D-glucitol alpha,5-diacetamido-2,4,6-triiodo-m-toluate
- Benzoic acid, 3-(acetylamino)-5-((acetylamino)methyl)-2,4,6-triiodo-, compound with 1-deoxy-1-(methylamino)-D-glucitol (1:1)
- Glucitol, 1-deoxy-1-(methylamino)-, alpha,5-diacetamido-2,4,6-triiodo-m-toluate (salt), D-
Registry Numbers
CAS Registry Number
- 18656-21-8
FDA UNII
- 6X283535A3
Other Registry Numbers
- 16240-58-7
- 523-89-7
- 63087-14-9
System Generated Number
- 0018656218
Molecular Formulas
Molecular Formula
- C12-H11-I3-N2-O4.C7-H17-N-O5
Molecular Formula Fragments
- C12-H11-I3-N2-O4
- C7-H17-N-O5
- COMPONENT
Structure Descriptors
InChI
InChI=1S/C12H11I3N2O4.C7H17NO5/c1-4(18)16-3-6-8(13)7(12(20)21)10(15)11(9(6)14)17-5(2)19;1-8-2-4(10)6(12)7(13)5(11)3-9/h3H2,1-2H3,(H,16,18)(H,17,19)(H,20,21);4-13H,2-3H2,1H3/t;4-,5+,6+,7+/m.0/s1InChIKey
UYIPQECISAQMIU-WZTVWXICSA-NSmiles
CNC[C@H](O)Toxicity
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
dog | LD | intravenous | > 15mL/kg (15mL/kg) | Arzneimittel-Forschung. Drug Research. Vol. 15, Pg. 222, 1965. | |
guinea pig | LD50 | intraperitoneal | 15gm/kg (15000mg/kg) | CARDIAC: OTHER CHANGES BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD | Arzneimittel-Forschung. Drug Research. Vol. 15, Pg. 222, 1965. |
mammal (species unspecified) | LD50 | oral | > 20gm/kg (20000mg/kg) | Arzneimittel-Forschung. Drug Research. Vol. 15, Pg. 222, 1965. | |
mouse | LD50 | intracrebral | 200mg/kg (200mg/kg) | Arzneimittel-Forschung. Drug Research. Vol. 15, Pg. 222, 1965. | |
mouse | LD50 | intravenous | 9gm/kg (9000mg/kg) | CARDIAC: OTHER CHANGES BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD | Arzneimittel-Forschung. Drug Research. Vol. 15, Pg. 222, 1965. |
rabbit | LD50 | intravenous | 13200mg/kg (13200mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD CARDIAC: OTHER CHANGES | Arzneimittel-Forschung. Drug Research. Vol. 15, Pg. 222, 1965. |
rat | LD50 | intraperitoneal | 17900mg/kg (17900mg/kg) | CARDIAC: OTHER CHANGES BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD | Arzneimittel-Forschung. Drug Research. Vol. 15, Pg. 222, 1965. |
rat | LD50 | intravenous | 11400mg/kg (11400mg/kg) | CARDIAC: OTHER CHANGES BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD | Arzneimittel-Forschung. Drug Research. Vol. 15, Pg. 222, 1965. |